Politan Capital Management said its candidates captured two board seats in Thursday’s shareholder vote, citing a preliminary analysis.

Activist investor Politan Capital secured two board seats at medical technology company Masimo, ousting founder and CEO Joe ...

Masimo’s long-running proxy fight has come to a close, at least for now. | Masimo’s long-running proxy fight has come to a ...

Shares of Masimo (NASDAQ: MASI) are trading nearly 3% higher early on Friday after activist investor Politan Capital Management, owner of a 9% stake in the company, disclosed its two independent board ...

The People’s Bank of China announced that its five-year loan prime rate, which affects borrowing costs for households, would stay at 3.85 per cent and its one-year rate, which is tied to business ...

Masimo Corp shareholders elected both director candidates proposed by veteran activist investor Quentin Koffey's hedge fund ...

Masimo (NASDAQ:MASI) rose 3% after activist investor Politan Capital Management won two board seats after a bitter proxy ...

"There are certain pockets of talent that are really tight: People who understand large language models, deep learning ...

"We are united in our enthusiasm for Masimo’s future as a leading, innovation-focused growth company," the newest board ...

Joe Kiani, founder of a company that he built into billions of dollars of sales, was ousted from the board, according to an ...

Politan Capital Management (together with its affiliates, "Politan"), a 9% shareholder of Masimo Corporation ("Masimo" or the "Company") (NASDAQ: MASI), today commented on the outcome of the Company's ...

Masimo shareholders today will decide on a bitter proxy fight between the company's founder and CEO Joe Kiani and Politan ...